Skip to main content
BOLT
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
4
Price
$4.84
Mkt Cap
$9.3M
52W Low
$3.91
52W High
$9.248
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, BOLT was trading at $4.84 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.3M. The 52-week trading range was $3.91 to $9.25. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BOLT - Latest Insights

BOLT
Apr 28, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Bolt Biotherapeutics Schedules Annual Meeting, Discloses High Executive Compensation and Governance Lapses Amidst Going Concern
Sentiment: Negative
View Wiseek Article
BOLT
Mar 12, 2026, 4:07 PM EDT
Filing Type: 10-K
Importance Score:
9
Bolt Biotherapeutics Issues Going Concern Warning Amid Restructurings and Reverse Stock Split
Sentiment: Negative
View Wiseek Article
BOLT
Mar 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Bolt Biotherapeutics Reports Q4/FY25 Results, Projects Cash Runway into 2027 Amidst Going Concern
Sentiment: Neutral
View Wiseek Article
BOLT
Mar 12, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Bolt Biotherapeutics Extends Cash Runway into 2027, Reports Initial Positive Immune Response for BDC-4182
Sentiment: Neutral
View Wiseek Article
BOLT
Feb 26, 2026, 7:22 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Institutional Investors Reduce Stake Below 5% in Bolt Biotherapeutics
Sentiment: Negative
View Wiseek Article
BOLT
Feb 17, 2026, 8:11 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Major Investor Group Reduces Stake in Bolt Biotherapeutics
Sentiment: Negative
View Wiseek Article